Tag: Solosec
Lupin Pharmaceuticals gets FDA approval for SOLOSEC sNDA
Lupin Pharmaceuticals has secured approval from the US Food and Drug Administration for its supplemental new drug application (sNDA) to expand the indication of SOLOSEC ... Read More
Lupin Pharmaceuticals signs agreement with Exeltis to promote Solosec in US
Indian pharma company Lupin Pharmaceuticals has signed an agreement with Exeltis USA to promote its antimicrobial drug Solosec (secnidazole) in the US market. Solosec is ... Read More
Lupin acquires Symbiomix to strengthen women’s health specialty business
Lupin acquires Symbiomix Therapeutics : Generics pharma company Lupin based in Mumbai has announced the acquisition of Symbiomix Therapeutics through its US subsidiary in a ... Read More